Mouse studies hold promise for a simple treatment for an aggressive gastric tumor

Posted by on May 20, 2016 2:05 am
Categories: health

Patients with aggressive neuroendocrine tumors (NETs) have limited treatment options and there are few oncologists who are specialized in this relatively rare disease. Normally a total gastrectomy (removal of the stomach) is employed in these cases, with a subsequent dramatic reduction in the quality of life for patients. Now researchers have identified a mutation in the human ATP4a gene that is involved in the gastric acid secretion regulation and has been identified as responsible of an aggressive form of inherited, early-onset gastric NET.

Leave a Reply

Your email address will not be published. Required fields are marked *